To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Welltica+ on MSN
Important scientific developments of 2025
Medical research in 2025 highlighted a shift toward more accessible forms of care.
Investor's Business Daily on MSN
CRISPR Therapeutics shows rising price performance with jump to 82 RS rating
CRISPR Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 71 to 82.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback